Literature DB >> 6233838

Relationship between pigment accumulation and age in Alzheimer's disease and Down syndrome.

D M Mann, P O Yates, B Marcyniuk.   

Abstract

The amount of lipofuscin pigment within nerve cells of the nucleus basalis of Meynert and that of melanin pigment with nerve cells of locus ceruleus was measured in seven patients with Down syndrome, in 22 patients with Alzheimer's disease and in 18 controls ranging from 30 to 88 years of age. No significant differences in amount of either pigment in these cells at any age were noted between the patient groups and their age controls.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233838     DOI: 10.1007/bf00688473

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  SKELETAL MATURATION IN MONGOLISM (DOWN'S SYNDROME).

Authors:  J POZSONYI; D GIBSON; D E ZARFAS
Journal:  J Pediatr       Date:  1964-01       Impact factor: 4.406

2.  DISCUSSION ON THE MENTAL AND PHYSICAL SYMPTOMS OF THE PRESENILE DEMENTIAS: Joint Discussion No. 5.

Authors: 
Journal:  Proc R Soc Med       Date:  1933-06

3.  The quantitative assessment of lipofuscin pigment, cytoplasmic RNA and nucleolar volume in senile dementia.

Authors:  D M Mann; K G Sinclair
Journal:  Neuropathol Appl Neurobiol       Date:  1978 Mar-Apr       Impact factor: 8.090

4.  Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells.

Authors:  D M Mann; P O Yates
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

5.  Lipoprotein pigments--their relationship to ageing in the human nervous system. I. The lipofuscin content of nerve cells.

Authors:  D M Mann; P O Yates
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

6.  Neuromelanin and RNA in cells of substantia nigra.

Authors:  D M Mann; P O Yates; C M Barton
Journal:  J Neuropathol Exp Neurol       Date:  1977 Mar-Apr       Impact factor: 3.685

7.  Alzheimer's disease and Down's syndrome.

Authors:  D L Price; P J Whitehouse; R G Struble; J T Coyle; A W Clark; M R Delong; L C Cork; J C Hedreen
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

8.  Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Neuropathol Appl Neurobiol       Date:  1984 May-Jun       Impact factor: 8.090

9.  The relationship between lipofuscin pigment and ageing in the human nervous system.

Authors:  D M Mann; P O Yates; J E Stamp
Journal:  J Neurol Sci       Date:  1978-06       Impact factor: 3.181

10.  Changes in the monoamine containing neurones of the human CNS in senile dementia.

Authors:  D M Mann; J Lincoln; P O Yates; J E Stamp; S Toper
Journal:  Br J Psychiatry       Date:  1980-06       Impact factor: 9.319

View more
  2 in total

1.  Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

Authors:  A D Snow; H Mar; D Nochlin; R T Sekiguchi; K Kimata; Y Koike; T N Wight
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

Review 2.  Monoamine neurons in aging and Alzheimer's disease.

Authors:  A M Palmer; S T DeKosky
Journal:  J Neural Transm Gen Sect       Date:  1993
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.